"The U.S. Food and Drug Administration today approved the MemoryShape Breast Implant to increase breast size (augmentation) for use in women at least 22 years old and to rebuild breast tissue (reconstruction) in women of any age. The MemoryShape B"...
NeoProfen may alter signs of infection. Patients' caregivers should be informed that the infant will be carefully monitored for any signs of infection.
Patients' caregivers should be informed that like other NSAIDS, NeoProfen can inhibit clot formation therefore their infant will be monitored for any signs of bleeding.
Patients' caregivers should be informed that the infants' blood will be tested for increased levels of total bilirubin.
Patients' caregivers should be informed that the infants' skin and tissues will be monitored as leakage from administration may be irritating to tissue.
Last reviewed on RxList: 12/12/2013
This monograph has been modified to include the generic and brand name in many instances.
Additional NeoProfen Information
- NeoProfen Drug Interactions Center: ibuprofen lysine (pf) iv
- NeoProfen Side Effects Center
- NeoProfen FDA Approved Prescribing Information including Dosage
Report Problems to the Food and Drug Administration
Find out what women really need.